Credit Suisse Ag Vericel Corp Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Vericel Corp stock. As of the latest transaction made, Credit Suisse Ag holds 66,010 shares of VCEL stock, worth $2.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

66,010

Previous 65,883 0.19%

Holding current value

$2.98 Million

Previous $2.35 Million 46.33%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$32.52 - $52.33 $4,130 - $6,645	127 Added 0.19%	66,010 $3.43 Million
Q4 2023 Feb 08, 2024	BUY	$30.85 - $37.09 $76,785 - $92,317	2,489 Added 3.93%	65,883 $2.35 Million
Q3 2023 Nov 13, 2023	SELL	$31.69 - $39.25 $156,548 - $193,895	-4,940 Reduced 7.23%	63,394 $2.12 Million
Q2 2023 Aug 11, 2023	BUY	$29.0 - $38.37 $441,612 - $584,298	15,228 Added 28.67%	68,334 $2.57 Million
Q1 2023 May 10, 2023	SELL	$23.85 - $31.34 $138,878 - $182,492	-5,823 Reduced 9.88%	53,106 $1.56 Million

Q4 2022 Feb 13, 2023	BUY	$17.65 - $27.37 $112,924 - $175,113	6,398 Added 12.18%	58,929 $1.55 Million
Q3 2022 Nov 10, 2022	BUY	$22.62 - $32.54 $95,614 - $137,546	4,227 Added 8.75%	52,531 $1.22 Million
Q2 2022 Aug 12, 2022	SELL	$22.88 - $39.45 $13,522 - $23,314	-591 Reduced 1.21%	48,304 $1.22 Million
Q1 2022 May 16, 2022	BUY	$31.69 - $43.29 $64,615 - $88,268	2,039 Added 4.35%	48,895 $1.87 Million
Q4 2021 Feb 14, 2022	SELL	$35.2 - $52.6 $20,204 - $30,192	-574 Reduced 1.21%	46,856 $1.84 Million
Q3 2021 Nov 12, 2021	SELL	$46.35 - $59.75 $139,652 - $180,026	-3,013 Reduced 5.97%	47,430 $2.31 Million
Q2 2021 Aug 16, 2021	BUY	$47.2 - $67.81 $234,206 - $336,473	4,962 Added 10.91%	50,443 $2.65 Million
Q1 2021 May 14, 2021	SELL	$30.93 - $59.48 $1.16 Million - $2.24 Million	-37,627 Reduced 45.27%	45,481 $2.53 Million
Q4 2020 Feb 12, 2021	BUY	$18.53 - $31.5 $130,043 - $221,067	7,018 Added 9.22%	83,108 $2.57 Million
Q3 2020 Nov 13, 2020	SELL	$14.68 - $19.12 $862,875 - $1.12 Million	-58,779 Reduced 43.58%	76,090 $1.41 Million
Q2 2020 Aug 12, 2020	BUY	$8.5 - $15.82 $715,759 - $1.33 Million	84,207 Added 166.21%	134,869 $1.86 Million
Q1 2020 May 13, 2020	SELL	$7.25 - $19.22 $340,960 - $903,897	-47,029 Reduced 48.14%	50,662 $464,000
Q4 2019 Feb 12, 2020	BUY	$13.77 - $19.2 $545,691 - $760,876	39,629 Added 68.25%	97,691 $1.7 Million
Q3 2019 Nov 12, 2019	BUY	$14.93 - $19.83 $144,582 - $192,033	9,684 Added 20.02%	58,062 $879,000
Q2 2019 Aug 14, 2019	BUY	$15.01 - $18.89 $361,380 - $454,795	24,076 Added 99.07%	48,378 $914,000
Q1 2019 May 14, 2019	BUY	$16.23 - $20.29 $16,960 - $21,203	1,045 Added 4.49%	24,302 $426,000
Q4 2018 Feb 13, 2019	BUY	$10.77 - $18.44 $250,477 - $428,859	23,257 New	23,257 $405,000
Q3 2018 Nov 13, 2018	SELL	$9.1 - $14.8 $112,521 - $183,002	-12,365 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$9.6 - $14.6 $118,704 - $180,529	12,365 New	12,365 $120,000

Others Institutions Holding VCEL

# of Institutions

263

Shares Held

48.9M

Call Options Held

150K

Put Options Held

128K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.13B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account